Mental Health Factors in Semaglutide Discontinuation—Reply
In Reply We thank Endo and Kami for their comments and for raising these questions in response to our post hoc analysis of the psychiatric safety of semaglutide, 2.4 mg, for weight management in persons without known major psychopathology, as evaluated in the STEP 1, 2, 3, and 5 studies.1
Authors
- Robert F. Kushner (ORCID: https://orcid.org/0000-0002-1380-3705)
- Ofir Frenkel
- Thomas A. Wadden
Institutions
- Northwestern University (US)
- Novo Nordisk (Denmark) (DK)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1001/jamainternmed.2024.8393
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00